Enzo Biochem, Inc.
ENZ was delisted on the 17th of April, 2025.
82 hedge funds and large institutions have $94.5M invested in Enzo Biochem, Inc. in 2021 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 19 increasing their positions, 33 reducing their positions, and 11 closing their positions.
28% more capital invested
Capital invested by funds: $73.8M → $94.5M (+$20.7M)
2% less funds holding
Funds holding: 84 → 82 (-2)
18% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 11
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
42% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 33
92% less call options, than puts
Call options by funds: $492K | Put options by funds: $6.23M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$477K |
| 2 |
Group One Trading
Chicago,
Illinois
|
+$308K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$189K |
| 4 |
Millennium Management
New York
|
+$162K |
| 5 |
Two Sigma Investments
New York
|
+$133K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
Ariel Investments
Chicago,
Illinois
|
-$1.97M |
| 2 |
HFA
Harbert Fund Advisors
Birmingham,
Alabama
|
-$1.38M |
| 3 |
Renaissance Technologies
New York
|
-$670K |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$416K |
| 5 |
VCA
VIEX Capital Advisors
Sunny Isles Beach,
Florida
|
-$392K |
ENZ Hedge Fund Activity: Q1 2021 in Review
82 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Enzo Biochem, Inc. (ENZ) for Q1 2021, worth a combined $94.5M — up 28% from $73.8M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of ENZ and 9 opened new positions — a net loss of 2 holders — while 33 trimmed existing stakes and 19 added.
The largest buyer was BlackRock, adding an estimated $477K. The largest seller was Ariel Investments, cutting an estimated $1.97M.
- 82 institutional investors held Enzo Biochem, Inc. (ENZ) as of Q1 2021, down from 84 in Q4 2020.
- Funds reported $94.5M of Enzo Biochem, Inc. stock for Q1 2021, up 28% quarter-over-quarter.
- 9 funds opened new Enzo Biochem, Inc. positions in Q1 2021 and 11 closed out, a net change of -2 holders.
- The largest Enzo Biochem, Inc. buyer in Q1 2021 was BlackRock, an estimated $477K added.
- The largest Enzo Biochem, Inc. seller in Q1 2021 was Ariel Investments, an estimated $1.97M sold.
Based on aggregated 13F filings for Q1 2021.